Seladelpar sodium salt
|
S659166-5mg
|
≥98% |
N/A |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
Seladelpar sodium salt
|
S659166-50mg
|
≥98% |
N/A |
50mg
|
¥ 4900.9
|
期货,请咨询 |
阿拉丁 |
Seladelpar sodium salt
|
S659166-10mg
|
≥98% |
N/A |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Secretin (28-54), human TFA
|
S659149-5mg
|
≥98% |
N/A |
5mg
|
¥ 5400.9
|
期货,请咨询 |
阿拉丁 |
Secretin (28-54), human TFA
|
S659149-1mg
|
≥98% |
N/A |
1mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
SAG dihydrochloride
|
S659134-5mg
|
Moligand™, ≥98% |
2702366-44-5 |
5mg
|
¥ 939.9
|
期货,请咨询 |
阿拉丁 |
SAG dihydrochloride
|
S659134-50mg
|
Moligand™, ≥98% |
2702366-44-5 |
50mg
|
¥ 3899.9
|
期货,请咨询 |
阿拉丁 |
SAG dihydrochloride
|
S659134-1mg
|
Moligand™, ≥98% |
2702366-44-5 |
1mg
|
¥ 399.9
|
期货,请咨询 |
阿拉丁 |
SAG dihydrochloride
|
S659134-10mg
|
Moligand™, ≥98% |
2702366-44-5 |
10mg
|
¥ 1499.9
|
期货,请咨询 |
阿拉丁 |
SAH-SOS1A TFA
|
S659123-5mg
|
≥99% |
N/A |
5mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
SAH-SOS1A TFA
|
S659123-10mg
|
≥99% |
N/A |
10mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
SPAA-52
|
S659120-5mg
|
≥98% |
N/A |
5mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
SPAA-52
|
S659120-50mg
|
≥98% |
N/A |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
SPAA-52
|
S659120-25mg
|
≥98% |
N/A |
25mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
SPAA-52
|
S659120-10mg
|
≥98% |
N/A |
10mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
SPAA-52
|
S659120-100mg
|
≥98% |
N/A |
100mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
Seco Rapamycin ethyl ester
|
S659102-5mg
|
≥85% |
N/A |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
Seco Rapamycin ethyl ester
|
S659102-50mg
|
≥85% |
N/A |
50mg
|
¥ 22000.9
|
期货,请咨询 |
阿拉丁 |
Seco Rapamycin ethyl ester
|
S659102-10mg
|
≥85% |
N/A |
10mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
SNIPER(TACC3)-1
|
S659100-5mg
|
≥99% |
N/A |
5mg
|
¥ 5100.9
|
期货,请咨询 |
阿拉丁 |
SNIPER(TACC3)-1
|
S659100-10mg
|
≥99% |
N/A |
10mg
|
¥ 8200.9
|
期货,请咨询 |
阿拉丁 |
Sofosbuvir impurity E
|
S659099-5mg
|
|
N/A |
5mg
|
¥ 35000.9
|
期货,请咨询 |
阿拉丁 |
Sofosbuvir impurity E
|
S659099-1mg
|
|
N/A |
1mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
Samuraciclib hydrochloride hydrate
|
S659091-5mg
|
≥99% |
N/A |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |